What is the share price of Procter & Gamble Health Ltd (PGHL) today?
The share price of PGHL as on 4th March 2026 is ₹4859. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Procter & Gamble Health Ltd (PGHL) share?
The past returns of Procter & Gamble Health Ltd (PGHL) share are- Past 1 week: -5.07%
- Past 1 month: -7.86%
- Past 3 months: -17.00%
- Past 6 months: -24.81%
- Past 1 year: -4.73%
- Past 3 years: -2.38%
- Past 5 years: -27.47%
What are the peers or stocks similar to Procter & Gamble Health Ltd (PGHL)?
The peers or stocks similar to Procter & Gamble Health Ltd (PGHL) include:What is the dividend yield % of Procter & Gamble Health Ltd (PGHL) share?
The current dividend yield of Procter & Gamble Health Ltd (PGHL) is 2.57.What is the market cap of Procter & Gamble Health Ltd (PGHL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Procter & Gamble Health Ltd (PGHL) is ₹8065.64 Cr as of 4th March 2026.What is the 52 week high and low of Procter & Gamble Health Ltd (PGHL) share?
The 52-week high of Procter & Gamble Health Ltd (PGHL) is ₹6739 and the 52-week low is ₹4841.10.What is the PE and PB ratio of Procter & Gamble Health Ltd (PGHL) stock?
The P/E (price-to-earnings) ratio of Procter & Gamble Health Ltd (PGHL) is 34.41. The P/B (price-to-book) ratio is 15.02.Which sector does Procter & Gamble Health Ltd (PGHL) belong to?
Procter & Gamble Health Ltd (PGHL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Procter & Gamble Health Ltd (PGHL) shares?
You can directly buy Procter & Gamble Health Ltd (PGHL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Procter & Gamble Health Ltd
PGHL Share Price
NSE₹4,859.002.58% (-128.60)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
PGHL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
PGHL Performance & Key Metrics
PGHL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 27.48 | 15.02 | 2.57% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.25 | 5.72 | 0.59% |
PGHL Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
PGHL Company Profile
Procter & Gamble Health Limited, formerly Merck Limited, is engaged in manufacturing and marketing of pharmaceuticals, bulk drugs, fine chemicals and pigments
SUNPHARMA
PE Ratio
38.43
38.43
1Y Return
11.75%
11.75%
Buy Reco %
94.29
94.29
TORNTPHARM
PE Ratio
76.87
76.87
1Y Return
48.14%
48.14%
Buy Reco %
81.48
81.48
DRREDDY
PE Ratio
19.01
19.01
1Y Return
15.27%
15.27%
Buy Reco %
48.39
48.39
CIPLA
PE Ratio
20.12
20.12
1Y Return
6.32%
6.32%
Buy Reco %
54.84
54.84
LUPIN
PE Ratio
32.10
32.10
1Y Return
18.01%
18.01%
Buy Reco %
72.22
72.22
PGHL Sentiment Analysis
PGHL Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
PGHL Stock Summary · June 2025
The company demonstrated robust fiscal performance for the nine-month period ending March 31, 2025, with an 8% sales increase and a remarkable 27% rise in profit after tax, underscoring the effectiveness of its integrated growth strategy. Despite navigating a challenging macroeconomic landscape, management remains committed to enhancing product superiority and expanding market share, particularly through innovative e-commerce initiatives and a new distribution model aimed at rural outreach. The emphasis on consumer health, particularly addressing Vitamin B deficiency, has fostered positive market sentiment, bolstered by educational campaigns that raise awareness of product benefits. Continuous engagement with healthcare professionals and consumer feedback integration are pivotal in driving innovation and maintaining brand loyalty, positioning the company for sustained growth and operational excellence.
PGHL Stock Growth Drivers
PGHL Stock Growth Drivers
6Strong Financial Performance
The company has reported significant financial achievements, including an 8% increase in sales to Rs.
Effective Integrated Growth Strategy
The company's Integrated Growth Strategy has been pivotal in driving growth and profitability. It focuses
PGHL Stock Challenges
PGHL Stock Challenges
0
Hmm, looks like there are nochallenges
PGHL Forecast
PGHL Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
PGHL
PGHL
Income
Balance Sheet
Cash Flow
Quarterly Normal View
PGHL Income Statement
PGHL Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 310.98 | 315.15 | 254.75 | 286.01 | 316.69 | 313.73 | 314.10 | 342.77 | 329.87 | 378.22 | ||||||||||
Operating & Other expenses | 216.27 | 208.32 | 185.04 | 255.82 | 199.37 | 186.34 | 230.07 | 248.40 | 204.65 | 263.40 | ||||||||||
EBITDA | 94.71 | 106.83 | 69.71 | 30.19 | 117.32 | 127.39 | 84.03 | 94.37 | 125.22 | 114.82 | ||||||||||
| Depreciation/Amortization | 6.48 | 6.92 | 6.84 | 7.16 | 5.77 | 5.55 | 5.37 | 5.44 | 6.08 | 5.90 | ||||||||||
| PBIT | 88.23 | 99.91 | 62.87 | 23.03 | 111.55 | 121.84 | 78.66 | 88.93 | 119.14 | 108.92 | ||||||||||
| Interest & Other Items | 0.18 | 0.19 | 0.15 | 0.20 | 0.15 | 0.15 | 0.13 | 0.12 | 0.12 | 0.10 | ||||||||||
| PBT | 88.05 | 99.72 | 62.72 | 22.83 | 111.40 | 121.69 | 78.53 | 88.81 | 119.02 | 108.82 | ||||||||||
| Taxes & Other Items | 22.48 | 27.65 | 16.16 | 6.05 | 29.07 | 30.79 | 17.35 | 22.63 | 30.48 | 31.23 | ||||||||||
| Net Income | 65.57 | 72.07 | 46.56 | 16.78 | 82.33 | 90.90 | 61.18 | 66.18 | 88.54 | 77.59 | ||||||||||
| EPS | 39.50 | 43.40 | 28.00 | 9.50 | 49.60 | 54.76 | 36.86 | 39.87 | 53.34 | 46.74 |
PGHL Company Updates
FY 2019FY 2019
PGHL Stock Peers
PGHL Past Performance & Peer Comparison
PGHL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Procter & Gamble Health Ltd | 34.41 | 15.02 | 2.57% |
| Sun Pharmaceutical Industries Ltd | 38.43 | 5.79 | 0.91% |
| Torrent Pharmaceuticals Ltd | 76.87 | 19.36 | 0.74% |
| Dr Reddy's Laboratories Ltd | 19.01 | 3.17 | 0.62% |
PGHL Stock Price Comparison
Compare PGHL with any stock or ETFCompare PGHL with any stock or ETF
PGHL
PGHL Holdings
PGHL Shareholdings
PGHL Promoter Holdings Trend
PGHL Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
PGHL Institutional Holdings Trend
PGHL Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
PGHL Shareholding Pattern
PGHL Shareholding Pattern
PGHL Shareholding History
PGHL Shareholding History
Foreign Institutions
Mutual Funds Invested in PGHL
Mutual Funds Invested in PGHL
No mutual funds holding trends are available
Top 5 Mutual Funds holding Procter & Gamble Health Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 4.4367% | Percentage of the fund’s portfolio invested in the stock 0.56% | Change in the portfolio weight of the stock over the last 3 months -0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 78/249 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.3379% | Percentage of the fund’s portfolio invested in the stock 2.38% | Change in the portfolio weight of the stock over the last 3 months -0.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 7/119 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.4704% | Percentage of the fund’s portfolio invested in the stock 4.42% | Change in the portfolio weight of the stock over the last 3 months -0.15% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 4/60 (-2) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing PGHL stock
smallcases containing PGHL stock
Looks like this stock is not in any smallcase yet.
PGHL Events
PGHL Events
PGHL Dividend Trend
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 2.51%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹25.06 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
PGHL Dividend Trend
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 2.51%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹25.06 every year
PGHL Upcoming Dividends
PGHL Upcoming Dividends
No upcoming dividends are available
PGHL Past Dividends
PGHL Past Dividends
Cash Dividend
Ex DateEx DateFeb 12, 2026
Special
Special | Div/Share: ₹50.00
Dividend/Share
₹50.00
Ex DateEx Date
Feb 12, 2026
Cash Dividend
Ex DateEx DateFeb 12, 2026
Interim
Interim | Div/Share: ₹110.00
Dividend/Share
₹110.00
Ex DateEx Date
Feb 12, 2026
Cash Dividend
Ex DateEx DateAug 22, 2025
Final
Final | Div/Share: ₹45.00
Dividend/Share
₹45.00
Ex DateEx Date
Aug 22, 2025
Cash Dividend
Ex DateEx DateFeb 21, 2025
Interim
Interim | Div/Share: ₹80.00
Dividend/Share
₹80.00
Ex DateEx Date
Feb 21, 2025
Cash Dividend
Ex DateEx DateNov 28, 2024
Final
Final | Div/Share: ₹60.00
Dividend/Share
₹60.00
Ex DateEx Date
Nov 28, 2024
PGHL Stock News & Opinions
PGHL Stock News & Opinions
Articles & Videos
Earnings
Procter & Gamble Health standalone net profit declines 14.64% in the December 2025 quarter
Net profit of Procter & Gamble Health declined 14.64% to Rs 77.59 crore in the quarter ended December 2025 as against Rs 90.90 crore during the previous quarter ended December 2024. Sales rose 20.69% to Rs 373.86 crore in the quarter ended December 2025 as against Rs 309.77 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales373.86309.77 21 OPM %29.5539.85 - PBDT114.72127.24 -10 PBT108.82121.69 -11 NP77.5990.90 -15 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Board of Procter & Gamble Health recommends Interim Dividend
Procter & Gamble Health announced that the Board of Directors of the Company at its meeting held on 06 February 2026, has recommended a Interim Dividend of Rs.110 per share (i.e.1100%), subject to the approval of the shareholders.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Board of Procter & Gamble Health recommends One-time Special Dividend
Procter & Gamble Health announced that the Board of Directors of the Company at its meeting held on 06 February 2026, has recommended a One-time Special Dividend of Rs.50 per share (i.e.500%), subject to the approval of the shareholders.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Procter & Gamble Health fixes record date for interim dividend
Procter & Gamble Health has fixed 12 February 2026 as record date for payment of interim dividend of Rs 160 per equity share (including a one-time special dividend of Rs 50 per equity share). The dividend will be paid on or before 04 March 2026. Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Procter & Gamble Health to declare Quarterly Results
Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Procter & Gamble Health standalone net profit rises 7.54% in the September 2025 quarter
Net profit of Procter & Gamble Health rose 7.54% to Rs 88.54 crore in the quarter ended September 2025 as against Rs 82.33 crore during the previous quarter ended September 2024. Sales rose 3.67% to Rs 324.92 crore in the quarter ended September 2025 as against Rs 313.41 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales324.92313.41 4 OPM %37.0236.39 - PBDT125.10117.17 7 PBT119.02111.40 7 NP88.5482.33 8 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Procter & Gamble Health to hold board meeting
Procter & Gamble Health will hold a meeting of the Board of Directors of the Company on 5 November 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Procter & Gamble Health announces change in HR leadership
Procter & Gamble Health announced that Anit Singh will be stepping down from his position as the Company's Human Resource Leader, effective 30 September 2025, as he moves on to a regional role in P&G as Director- Humar Resources, SK II- Japan and Tokyo. Sanika Gokhale will take over as Human Resource Leader of the Company starting 01 October 2025. Sanika Gokhale has a Post Graduate Diploma in Human resource Management, from Xavier School of Management- Jamshedpur (2015) and Bachelors of Mass Media from Mumbai University. Ms. Gokhale has a work experience of 10 years, and has been associated with the P&G group for the last 7 years. Ms. Gokhale has handled multiple roles with increasing accountability in her 7 years with P leading Human Resources Operations; Business partnering for Category teams within the P&G group in India and most recently, leading India Talent Practice and E&I for the region.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Procter & Gamble Health to convene AGM
Procter & Gamble Health announced that the Annual General Meeting(AGM) of the company will be held on 29 August 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Procter & Gamble Health standalone net profit rises 294.40% in the June 2025 quarter
Net profit of Procter & Gamble Health rose 294.40% to Rs 66.18 crore in the quarter ended June 2025 as against Rs 16.78 crore during the previous quarter ended June 2024. Sales rose 19.33% to Rs 338.74 crore in the quarter ended June 2025 as against Rs 283.88 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales338.74283.88 19 OPM %26.6717.00 - PBDT94.2550.18 88 PBT88.8143.02 106 NP66.1816.78 294 Powered by Capital Market - Live
7 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -7.89%, vs industry avg of 9.88%
Over the last 5 years, market share decreased from 0.56% to 0.22%
Over the last 5 years, net income has grown at a yearly rate of -1.6%, vs industry avg of 19.69%